Joshua Hexter
From Bangladesh to Israel and Oramed Pharmaceuticals – whose oral insulin development you can read about here – have appointed Joshua Hexter as Chief Operating Officer and Vice President of Business Development.
Hexter, who was most recently Executive Director of Corporate In-Licensing at BioLineRx, has more than 15 years of biotech leadership experience and, according to Oramed CEO Nadav Kidron: “Will be a great addition and complement to Oramed's executive team as we enter a new era in our clinical trials and activities.”